Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2017

Overview

The Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2017 is an instrument made under the Therapeutic Goods Act 1989 with the aim of clarifying the scope of what constitutes a medical device. This legislative instrument was introduced to address the problem of ambiguity regarding the classification of certain articles that, through chemical means, alter the pH level of body fluids, including those in body orifices. The enacting body responsible for this order is Cheryl McRae, a delegate of the Secretary of the Department of Health. The policy objective of the order is to provide clarity and ensure that materials or other articles intended to change the pH level of body fluids are not classified as medical devices under the Act. This order aims to streamline regulatory oversight and ensure that these products are subject to the appropriate regulatory requirements, thereby maintaining public health and safety.

Scope and Application

The Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2017 is a specific regulatory instrument made under the Therapeutic Goods Act 1989, which pertains to therapeutic goods within the Commonwealth of Australia. This order applies to materials or other articles that are intended to alter the pH level of body fluids through chemical means, including within a body orifice. The scope of this order explicitly excludes such articles from being classified as medical devices under the Act, thereby ensuring they are regulated appropriately under different provisions. The order applies nationally across Australia, given its basis under Commonwealth legislation, and it came into effect on the day following its registration. Notably, this order does not create any new exclusions or exemptions beyond the specific declaration regarding pH-altering articles; it operates within the broader framework of the Therapeutic Goods Act and associated regulations, including the Therapeutic Goods (Medical Devices) Regulations 2002. The application of this order can also be extended or refined through subordinate instruments as necessary.

Key Provisions

The Therapeutic Goods (Articles that are not Medical Devices) Order No. 2 of 2017 clarifies that certain materials and articles are not classified as medical devices under the Therapeutic Goods Act 1989 (the Act). Specifically, Section 4 declares that any material or article that is intended to alter the pH level of body fluids, either generally or in a body orifice, does not fall under the category of a medical device (Section 4). This order is significant as it delineates the scope of what is not considered a medical device, thereby excluding these items from the regulatory requirements that apply to medical devices. This legislative instrument imposes specific obligations on entities involved in the manufacture, supply, or importation of such materials and articles. Although they are not classified as medical devices, these items must still comply with general safety and quality standards under the Act (Section 10). Manufacturers, suppliers, and importers must ensure that these products are safe for their intended use and that they do not pose a risk to consumers. They must also maintain records and documentation to demonstrate compliance with these standards (Section 11). Failure to comply with the obligations set forth in the Therapeutic Goods Act 1989 can lead to serious consequences. For example, if a product is found to be unsafe or does not meet the required standards, the Therapeutic Goods Administration (TGA) can take enforcement actions. The Act provides for both civil and criminal penalties. Civil penalties can include fines up to $222,222 for individuals and significantly higher amounts for corporations (Section 30). Criminal penalties can include fines of up to $1,111,111 and/or imprisonment for up to five years for individuals, and higher fines for corporations (Section 31). Additionally, the TGA can issue public warnings or require the recall of non-compliant products (Section 33). These stringent measures are in place to ensure that products on the market do not compromise public health and safety.